In multiple myeloma (MM), elevated TGF-β signaling within the tumor microenvironment correlated strongly with poor prognosis [36], while in lung adenocarcinoma (LUAD), high natural killer gene signature (NKGS) scores associated with TGF-β pathway genes predicted worse overall survival [37]. This evidence concerns the gene TGFB1 and plasma cell myeloma.